• Therapeutics
  • Protein Discovery
  • Technologies
  • Diagnostics
  • Partner

  • Resources

    Reading and writing the code of life

    • Publications

      Learn more about our technology

    • Newsroom

      Keep up with our latest news

  • Company

    Reading and writing the code of life

    • About

      Learn more about us

    • Careers

      We’re hiring!

    • Contact

      Get in touch with us

  • We’re hiring

Selected Publications

  • All
  • Diagnostics
  • Therapeutics
  • Protein Discovery
  • CRISPR-Based in vivo Gene Editing Using an Engineered CasPhi Nuclease for Durable Reduction of apoC-III Protein and Triglycerides to Treat Persistent Chylomicronemia

    Chen S, Bobbin M, Abe K, et al. American Heart Association Scientific Sessions 2026. Poster.
    Learn More
  • MB-CasFire™: A Plug-and-Play, Thermostable CRISPR Enzyme for Precise Nucleic Acid Detection

    Broughton JP, Alpay E, Fantin NJ, et al. medRxiv. 2026. doi:10.64898/2026.11.06.26367472
    Learn More
  • CRISPR-CasΦ from huge phages is a hypercompact genome editor

    Pausch P, Al-Shayeb B, Bisom-Rapp E, et al. Science. 2020 Jul 17; 369(6501): 333–337. doi: 10.1126/science.abb1400
    Learn More
  • CRISPR-Cas enzymes: The toolkit revolutionizing diagnostics

    Verosloff MS, Shapiro SJ, Hawkins EM, et al. Biotechnol J . 2021 Sep 10;e2100304. doi: 10.1002/biot.202100304.
    Learn More
  • CRISPR–Cas12-based detection of SARS-CoV-2

    Broughton JP, Deng X, Yu G. et al.
    Nat Biotechnology. 2020; doi:10.1038/s41587-020-0513-4
    Learn More
  • Massively parallel kinetic profiling of natural and engineered CRISPR nucleases.

    Jones SK, Hawkins JA, Johnson NV, Jung C, Hu K, Rybarski JR, Chen JS, Doudna JA, Press WH, Finkelstein IJ. https://www.biorxiv.org/content/10.1101/696393v1.
    Learn More
  • Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics.

    Ricci CG, Chen JS, Miao Y, et al. ACS Cent Sci. 2019;5(4):651–662. doi:10.1021/acscentsci.9b00020
    Learn More
  • A Functional Mini-Integrase in a Two-Protein-type V-C CRISPR System.

    Wright AV, Wang JY, Burstein D, et al. Mol Cell. 2019;73(4):727–737.e3. doi:10.1016/j.molcel.2018.12.015
    Learn More
  • Programmed DNA destruction by miniature CRISPR-Cas14 enzymes.

    Harrington LB, Burstein D, Chen JS, et al. Science. 2018;362(6416):839–842. doi:10.1126/science.aav4294
    Learn More
  • Posts navigation

    1 2 3 Next

Mammoth Biosciences, Inc.
1000 Marina Blvd.
Brisbane, CA 94005

info@mammothbiosci.com © 2024 Mammoth Biosciences, Inc. | Privacy Policy | Terms of Use